glutathione mutations in sclc patients Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming EGFR-Mutant Lung Cancer RETRACTED ARTICLE: Novel prognostic biomarkers
RETRACTED ARTICLE: Novel prognostic biomarkers in small cell lung cancer reveal mutational signatures, genomic mutations, and immune implications Scientific Reports Glutathione Dependent Pathways in Cancer Cells Impact of the deletion glutathione S transferase (class Mu) on lung cancer risk among smokers The Egyptian Journal of Bronchology Springer Nature Link Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications
Pay in 4 interest-free payments of $5.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



